NIVFW
NewGenIvf Group Limited WarrantsNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
-0.04
52W High
$0.04
52W Low
$0.01
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
209.00%
Forward P/E
—
PEG Ratio
—
About NewGenIvf Group Limited Warrants
NewGenIvf Group Limited Warrants (NIVFW) is an innovative biotechnology firm dedicated to advancing assisted reproductive technology (ART) and revolutionizing reproductive healthcare. The company focuses on increasing fertility success rates and improving care quality through cutting-edge research and technology, catering to the growing global demand for IVF services. With a strategic focus on meeting unmet needs in the fertility sector, NewGenIvf is well-positioned for growth, anticipating future partnerships and ongoing enhancements to maximize patient outcomes in a rapidly evolving market.
Fundamentals
| Revenue (TTM) | $4.73M |
| Gross Profit (TTM) | 955,850 |
| EBITDA | $-10.54M |
| Operating Margin | -349.10% |
| Return on Equity | 79.40% |
| Return on Assets | -36.90% |
| Revenue/Share (TTM) | $308.19 |
| Book Value | $331.51 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.90% |
| Shares Outstanding | 0 |
| Float | 187,370 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
—
HV 20-Day
—
HV 30-Day
—
HV 60-Day
—
HV Rank
—
Data last updated: 7/9/2026